Skip to main content

Lord, Abbett & Co. LLC

SEC CIK
0000728100
Latest filing
Aug 14, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q1 2025)
0
Sold out in Q1 2025
Value
$0
% of portfolio
0.0%
Quarters held
5
Since Q4 2023
Holdings of CRNX by Lord, Abbett & Co. LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20250$00.0%−724,625−100.0%Sold outHolders
Q4 2024724,625$37.0M0.1%−21,493−2.9%ReducedHolders
Q3 2024746,118$38.1M0.1%−141,803−16.0%ReducedHolders
Q2 2024887,921$39.8M0.1%−76,647−7.9%ReducedHolders
Q1 2024964,568$45.2M0.1%+187,280+24.1%AddedHolders
Q4 2023777,288$27.7M0.1%+777,288NewHolders